BOCCHIA MONICA

Contacts

Teaching activities

Completion accademic year: 2026/2027

Course year: 2 First cycle degree (DM 270) DIETISTIC A.Y. 2025/2026
Course year: 4 Full cicle (6 years) MEDICINA E CHIRURGIA A.Y. 2023/2024
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2024/2025
Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2025/2026
Course year: 4 Full cicle (6 years) MEDICINA E CHIRURGIA A.Y. 2023/2024

Completion accademic year: 2025/2026

Course year: 2 First cycle degree (DM 270) DIETISTIC A.Y. 2024/2025
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2022/2023
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2023/2024
Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2024/2025
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2022/2023

Research

Ultime pubblicazioni:

  • Pacini, E., Esposito Vangone, B., Santoni, A., Malchiodi, M., Zuanelli Brambilla, C., Sicuranza, A., et al. (2026). Impressive Skin and Systemic Response Despite Patient Underestimation and Delayed Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm. CASE REPORTS IN HEMATOLOGY, 2026(1) [10.1155/crh/4591883]. - view more
  • Gianesin, B., Zappu, A., Ferrero, G.B., Gaglioti, C.M., Santodirocco, M., Fania, G., et al. (2026). Real-world evidence supports the safety and efficacy profile of luspatercept in clinically complex and heavily iron-overloaded patients. BRITISH JOURNAL OF HAEMATOLOGY, 208(6), 2320-2325 [10.1111/bjh.70437]. - view more
  • Del Prete, R., Tusha, V., Simon-Molas, H., Gazziero, V.A., Nardi, F., Drago, R., et al. (2026). IL21—STAT3 controls the pentose phosphate pathway to support metabolic reprogramming and tumor progression in chronic lymphocytic leukemia. HEMASPHERE, 10(1) [10.1002/hem3.70292]. - view more
  • D'Amato, M., Rapolla, C.M., Benedetti, E., Bocchia, M., Capochiani, E., Carlomagno, G., et al. (2026). Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus. CLINICAL AND EXPERIMENTAL MEDICINE, 26(1) [10.1007/s10238-026-02100-y]. - view more
  • Palandri, F., Caocci, G., Abruzzese, E., Tiribelli, M., Morsia, E., Farina, M., et al. (2026). Survival and quality-of-life implications of cytopenia trajectories in ruxolitinib-treated myelofibrosis. CANCER, 132(4) [10.1002/cncr.70320]. - view more